GUGGENHIME ANDREW bought PCVX
February 26, 2026 · Form 4 insider transaction
GUGGENHIME ANDREW bought 44,864 shares of Vaxcyte, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
44,864
Price
$0.00
Total value
N/A
InsiderGUGGENHIME ANDREW
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateMarch 2, 2026
Shares owned after107,323
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 1/4 of the shares subject to the award on September 7, 2026 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.